Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	22301
Country	Canada

Received	2015-08-25 13:41
Peer-Review Started	2015-08-28 19:45
To Make the First Decision	2015-11-06 11:08
Return for Revision	2015-11-10 10:09
Revised	2015-11-11 00:01
Second Decision	2015-12-02 13:53
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-12-11 16:56
Articles in Press	2015-12-11 16:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-23 20:37
Publish the Manuscript Online	2016-01-31 19:20

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker
Manuscript Source	Invited Manuscript
All Author List	Alain Piché
Funding Agency and Grant Number	Funding Agency Grant Number Internal Funding from Université de Sherbrooke
Corresponding Author	Alain Piché, MD, Département de Microbiologie et Infectiologie, Faculté de Médecine, Université de Sherbrooke, 3001, 12ième Avenue Nord, Sherbrooke J1H 5N1, Canada. alain.piche@usherbrooke.ca
Key Words	MUC16; CA125; Mucin; Ovarian cancer; Tumorigenesis; Biomarker
Core Tip	MUC16/CA125 has been a mainstay biomarker for ovarian cancer but its pathobiological role has remained mostly unknown. Recent literature has shown that MUC16 is much more than a biomarker. MUC16 has oncogenic properties and plays an important role in tumorigenesis. Here, we will review the current knowledge regarding the oncogenic role of MUC16.
Publish Date	2016-01-31 19:20
Citation	Piché A. Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker. World J Obstet Gynecol 2016; 5(1): 39-49
URL	http://www.wjgnet.com/2218-6220/full/v5/i1/39.htm
DOI	http://dx.doi.org/10.5317/wjog.v5.i1.39

Full Article (PDF)	WJOG-5-39.pdf
Full Article (Word)	WJOG-5-39.doc
Manuscript File	22301-Review.docx
Answering Reviewers	22301-Answering reviewers.pdf
Audio Core Tip	22301-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22301-Conflict-of-interest statement.pdf
Copyright License Agreement	22301-Copyright assignment.pdf
Peer-review Report	22301-Peer-review(s).pdf
Scientific Misconduct Check	22301-Scientific misconduct check.pdf
Scientific Editor Work List	22301-Scientific editor work list.pdf